‌

US Patent 10759796 CXCR4 inhibitors and uses thereof

Patent 10759796 was granted and assigned to X4 Pharmaceuticals on September, 2020 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors

Is a

Patent

Patent attributes

Patent Applicant

X4 Pharmaceuticals

Current Assignee

X4 Pharmaceuticals

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

107597960

Date of Patent

September 1, 2020

Patent Application Number

163110200

Date Filed

June 21, 2017

Patent Citations Received

‌

US Patent 11857551 Methods for the prevention and treatment of hearing loss

‌

US Patent 11332470 CXCR4 inhibitors and uses thereof

‌

US Patent 11337969 Methods for treating cancer

‌

US Patent 11780837 CXCR4 inhibitors and uses thereof

‌

US Patent 10988465 CXCR4 inhibitors and uses thereof

‌

US Patent 11306088 CXCR4 inhibitors and uses thereof

Patent Primary Examiner

‌

Joseph R Kosack

No article content yet.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 10759796 CXCR4 inhibitors and uses thereof

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API